The Implantation Under Echography of Fiducial Markers in the Intraprostatic Lesion and Prostate
NCT ID: NCT00841685
Last Updated: 2023-01-05
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
25 participants
INTERVENTIONAL
2008-12-31
2012-05-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
SmartTarget: BIOPSY
NCT02341677
Using Fiducial Markers to Aid in Prostate Cancer Radiation Treatment
NCT00061347
Evaluation of Radiation Therapy Positioning System (RTPS) in Patients With Localized Prostate Cancer
NCT00921193
Rectal Spacers in Prostate Cancer Patients Undergoing Radiation Therapy
NCT06599476
Prostate Localization During Radiotherapy Using a Ni-Ti Stent and Electronic Portal Imaging - Protocol II
NCT00250224
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
OTHER
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
1
Goldlock
Goldlock
Insertion of Goldlock marker
2
Visicoil smallest size
Visicoil smallest size
Insertion of Visicoil, smallest size, marker
3
Visicoil larger size
Visicoil larger size
Insertion of Visicoil, larger size, marker
4
Bard goldmarker smallest size
Bard goldmarker smallest size
Insertion of Bard goldmarker, smallest size
5
Bard goldmarker larger size
Bard goldmarker larger size
Insertion of Bard goldmarker, larger size
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Goldlock
Insertion of Goldlock marker
Visicoil smallest size
Insertion of Visicoil, smallest size, marker
Visicoil larger size
Insertion of Visicoil, larger size, marker
Bard goldmarker smallest size
Insertion of Bard goldmarker, smallest size
Bard goldmarker larger size
Insertion of Bard goldmarker, larger size
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* T1-T4 tumors
* Radiotherapy as primary therapy +/- androgen deprivation
* Presence of an intraprostatic lesion (IPL) on MRI/MRS
* Presence of an intraprostatic lesion (IPL) on ultrasound
* WHO 0-2
Exclusion Criteria
* No written informed consent
18 Years
MALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
IBA, Germany
UNKNOWN
Hospimed, Netherland
UNKNOWN
Bard Ltd
INDUSTRY
University Hospital, Ghent
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Gert De Meerleer, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
University Hospital, Ghent
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University Hospital Ghent
Ghent, , Belgium
Countries
Review the countries where the study has at least one active or historical site.
Related Links
Access external resources that provide additional context or updates about the study.
Website of the University Hospital Ghent
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2008/109
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.